PPT-Medical Marijuana/Cannabis

How when why should it fit   Kimberly Angelia Curseen MD Associate Professor of Internal Medicine Emory Palliative Care Center Emory School of Medicine Director of Emory Outpatient SupportivePalliative Care Clinic. Cannabis contains a number of active substances like dronabinol THC and cannabidiol CBD THC is mainly responsible for the e64256ects of cannabis but others like CBD may also in64258uence the e64256ectiveness of the drug The chemical composition of Prepared by Dr Amir Barsoum, MD, FRCPC. Home on the Hill Lecture Series. Sept 16, 2015. Objectives. Discuss definitions and concepts relating to psychosis. Review demographics and effects of marijuana use. Eddie Cooke. Shannon Miller . Rules . F. or Discussion . No interrupting. No degrading or rude comments to other students. Everyone has a right to their own opinion. D. o not use names if talking about a situation. Spinal Stenosis, Pain and Medicinal Marijuana. PSP Managing Pain Cases. Explain the physician’s role in the MMPR (Marijuana for Medical Purposes Regulations).. Describe a professional and responsible way to excuse yourself from that role if you are uncomfortable.. By: Phyliss Nicole Taylor, MD . Medical Director, Assistant Professor . UF Health Psychiatry . Financial Disclosures . None . Objectives. Understand what Amendment 2 means for FL physicians and patients. . Cannabis . Use for Chronic Pain. . Workshop.  . Oregon Pain . Guidance.  . 6th annual . Conference. Dan . Clauw. , MD. David Tauben, MD. 2. R. ick . Stevens. New Yorker Magazine. . Jan 18, 2010. Objectives. drug control . system and its effects on science. Tom Blickman– TNI. tblick@tni.org. The Rise and Decline of Cannabis Prohibition. The . History of Cannabis in the UN Drug Control System and Options For Reform. Gregg VandeKieft, MD, MA. WSHPCO “Expanding dimensions in hospice & palliative care”. Chelan, . wa. October 10, 2017. Disclosure. Dr. VandeKieft does not have any conflicts of interest to disclose. He will discuss medical applications of cannabis, but will not discuss off-label use of medications.. What’s Required and How to Advise?. Marijuana in the workplace. Today’s Agenda. Overview of Minnesota’ Medical Cannabis Law. 01. Rules for Accommodating . Medical Marijuana. Drug Testing for Medical Marijuana. Learning Objectives . Review the New Mexico Cannabis Program.. Describe how cannabis works in the body.. Identify available dosage forms and their benefits and cautions. . Identify common adverse effects of medical cannabis use.. . Launette Rieb . MD, MSc, CCFP, FCFP, dip ABAM. Clinical Associate Professor, UBC. Thoughtful . Approach to Chronic . Pain. Medford, Oregon, May 28-30, 2015. Faculty/Presenter Disclosure. Faculty: Launette Rieb. Marijuana in Maine Deanna L. White, AAG August 2, 2018 Short History of Federal Law Controlled Substances Act (1970) Regulates manufacture, possession, use, and distribution of certain drugs with abuse potential 2 nd Annual Spring Conference May 11 th 2018 CTN Agenda 2         2018 Spring Education Conference May 11 th 2018 Location:  Swedish Medical Center Conference Center   8:30 Registration/Light Breakfast provided by CTN What are the effects of the current cannabis policy? . How is cannabis policy changing in other states?. What technical elements need to be addressed? . What goals should Minnesota have for legalizing adult-use cannabis?.